Patent intelligence · US
US 8729027
Therapeutic agent for fibromyalgia containing etanercept
Therapeutic agent for fibromyalgia containing etanercept
Patent details — US 8729027
- Jurisdiction
- US
- Status
- granted
- Grant date
- May 20, 2014
- Expiration
- May 15, 2034
- Applicant
- AXIS
- Claims
- 3
- CPC classes
- A61K, A61K38/1793, A61K39/3955, A61P
Quick answer
US 8729027 (Therapeutic agent for fibromyalgia containing etanercept) is held by AXIS. Status: granted. Granted May 20, 2014. Expires May 15, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- AXIS
- Grant date
- Expiration
- Claims
- 3
- CPC classes
- A61K, A61K38/1793, A61K39/3955, A61P, A61P1/04, A61P13/12
More from AXIS
Related pharmaceutical patents in our USPTO index.
-
US 12404297
Salts and crystal forms of GABA-A positive allosteric modulator
granted -
US 12325711
3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-α]pyrazine as an ion channel modulator
granted -
US 12259378
Dynamic clamps and methods of use thereof
granted -
US 12145939
Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators
granted -
US 12077502
Formulations of T-type calcium channel modulators and methods of use thereof
granted -
US 11918571
Compounds and their methods of use
granted -
US 11919836
Prodrugs of fencamfamine
granted -
US 11866439
Ion channel modulators
granted
Related coverage
Frequently asked questions
What is US patent 8729027?
US 8729027 (Therapeutic agent for fibromyalgia containing etanercept) is held by AXIS. Status: granted. Granted May 20, 2014. Expires May 15, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8729027?
AXIS is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 35 pharmaceutical patents for this assignee.
When does US 8729027 expire?
Our index shows an expiration date of May 15, 2034 (8 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.